Hemopressin is an inverse agonist of CB1 cannabinoid receptors
about
Molecular model of cannabis sensitivity in developing neuronal circuitsHemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpefat/fat miceNovel endogenous peptide agonists of cannabinoid receptorsParsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNSWhy do cannabinoid receptors have more than one endogenous ligand?Hemopressin and other bioactive peptides from cytosolic proteins: are these non-classical neuropeptides?Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A reviewNatural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3ε and calmodulinIdentification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.Hemoglobin-derived peptides as novel type of bioactive signaling moleculesEndogenous peptide discovery of the rat circadian clock: a focused study of the suprachiasmatic nucleus by ultrahigh performance tandem mass spectrometry.Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic useA novel intracellular peptide derived from g1/s cyclin d2 induces cell deathAnalysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins.Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.The endocannabinoid system: potential for reducing cardiometabolic riskRole of antibodies in developing drugs that target G-protein-coupled receptor dimers.Inverse agonism and its therapeutic significance.A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.Multiple functions of endocannabinoid signaling in the brain.Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons.Functional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain.Peptidomic analysis of human cell lines.Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury painEndocannabinoid tone versus constitutive activity of cannabinoid receptors.Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions.Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model.Synthesis of hemopressin peptides by classical solution phase fragment condensationQuantitative peptidomics for discovery of circadian-related peptides from the rat suprachiasmatic nucleus.Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in micePost-activation-mediated changes in opioid receptors detected by N-terminal antibodies.Analysis of peptides secreted from cultured mouse brain tissueCannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feedingDynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.Endocannabinoids: A Promising Impact for Traumatic Brain Injury.Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuseEffects of opioids, cannabinoids, and vanilloids on body temperature.
P2860
Q24613715-2E51824F-5960-47A4-ADD4-6765967CEE44Q24623260-0D67463D-13D2-44C3-8D55-FBD753F21159Q24644673-8A747676-0657-4EA2-BD64-705C5C36F836Q26853436-232073F6-7C04-4EE1-92B5-C12DC446A84CQ26862444-0FB9A4FD-3203-4F8C-B465-6879CC7B3C5AQ27693906-E59F5E4A-11FD-4768-B0F6-C728B4C04C97Q28257062-5C3A6E92-F491-4528-8BCA-18FC30F40A5BQ28573313-3B92A8C5-1301-4CA5-8B92-D57A67585BBFQ30561814-A8144CAF-9A4F-46D5-8539-74D34A1423C8Q33682344-C3CB617F-8813-44F9-9853-1D9A42DBAA5AQ33697760-8CA2D996-6FF7-4762-929D-77D43263E0E0Q33723564-131DCDD4-BCD9-40C2-83BD-BE5BB5FB2FDBQ33761170-3B21ECA7-16E2-4799-98D4-86C8C0EDAA64Q33987281-DE1D1C18-A25A-4878-B60A-D5A3DAF88BB2Q33997873-729AC341-94B3-4588-819E-403613590E2AQ33999727-1C3A4A38-5888-4921-B452-2EC990FD1114Q34051430-571B49A5-66FC-415F-A6F8-EF0BCAAAEF86Q34226789-EB44763B-DD38-4E9E-AF95-18CB6CD9B2D6Q34264449-859866F8-4AFC-4822-B3FD-65E359113181Q34270199-225AA2D6-D181-468F-ABDA-778C7A4F67D2Q34352311-FAF6DF46-8BEA-4AA0-AF1D-72D2ED8AD20AQ34380550-DD38B967-2A5F-46F2-A14B-C38AE679D700Q34756925-7013EAD1-902F-4878-8AB1-1B5A000644D9Q35080630-C7690021-9C86-43E5-A6B8-96736A5421E7Q35175618-712601AE-BAF2-47F8-9436-FA34408FA28CQ35193265-739AD124-A199-4CD6-BE01-001A5485F731Q35421957-131E821A-AFE7-4386-8F3D-C6215A9B617AQ35894867-883E1F5E-7B12-4F6A-AD49-94D3B02FB309Q36071373-A3EC941E-81BD-4A36-A6A8-2BCD5783C1EBQ36446701-D435F29D-5112-4915-8E34-3ED37F9EA460Q36581951-93E9E44C-F962-4774-8FD9-3C462A3EFF6EQ36650335-9079A21F-96B6-487F-891F-EE06AD391448Q36749200-184B1748-5A63-4BD6-B289-5B27430D6A12Q36927122-6BE66547-488C-4485-8F33-C9A42F3AFDBEQ36953261-20A1E839-56BF-4052-B781-C463B672587CQ37218344-97B86FF8-0C5A-407F-97D9-B9C86818487FQ37349953-EED74B9D-1315-4B2A-97F1-0031AAC89AD8Q37648343-8E1873BC-9EB4-48AF-B58C-6970E61FD592Q37680038-5FDB941C-A525-4F62-9CD8-C3A99EA42997Q37692352-F56CCC08-128A-49A1-861B-E6C9BEC8670B
P2860
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@ast
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@en
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@nl
type
label
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@ast
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@en
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@nl
prefLabel
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@ast
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@en
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@nl
P2093
P2860
P921
P3181
P356
P1476
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
@en
P2093
Achla Gupta
Andrea S Heimann
Augusto D Luchessi
Camila S Dale
Emer S Ferro
Ivone Gomes
Lakshmi A Devi
Laura L de Souza
Renata Giorgi
Rosana L Pagano
P2860
P304
20588-20593
P3181
P356
10.1073/PNAS.0706980105
P407
P577
2007-12-12T00:00:00Z